Key facts
- This page summarizes William Michael Brown's Form 4 filing for Altimmune, Inc. (ALT).
- 1 reported transaction and 0 derivative rows are listed below.
- Accepted by SEC: 06 Aug 2021, 19:01.
Key filing fact
Ownership activity is grounded in SEC Form 4 disclosures.
Shares, units, or other non-derivative securities reported in this filing.
Award
Additional SEC filing notes
Footnote F1
These shares were purchased due to participation by the reporting individual in the Issuer's 2019 Employee Stock Purchase Plan ("ESPP"). It pertains to the ESPP purchase period from February 1, 2021 through July 31, 2021.
Footnote F2
In accordance with the ESPP, these shares were purchased based on 85% of the closing price of the issuer's common stock on July 31, 2021.